Log in to save to my catalogue

Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models

Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11735103

Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most frequently mutated oncogene in lung adenocarcinoma, with G12C and G12V being the most predominant forms. Recent breakthroughs in KRASG12C inhibitors have transformed the clinical management of patients with the G12C mutation and advanced our understanding of the function of this mutation...

Alternative Titles

Full title

Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11735103

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11735103

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI174249

How to access this item